- Sections
- C - Chimiemétallurgie
- C12R - Schéma d'indexation associé aux sous-classes , relatif aux micro-organismes
- C12R 1/21 - Haemophilus
Détention brevets de la classe C12R 1/21
Brevets de cette classe: 24
Historique des publications depuis 10 ans
|
3
|
0
|
0
|
2
|
2
|
1
|
2
|
0
|
2
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1646 |
2 |
| King Abdulaziz University | 510 |
2 |
| Tsinghua University | 5922 |
1 |
| Bontac Bio-Engineering (Shenzhen) Co., Ltd | 72 |
1 |
| CapitalBio Corporation | 96 |
1 |
| Fundacao Oswaldo Cruz | 105 |
1 |
| Intercell AG | 20 |
1 |
| Intervet International B.V. | 1283 |
1 |
| Merial, Inc. | 220 |
1 |
| Newport Laboratories, Inc. | 6 |
1 |
| The Penn State Research Foundation | 1518 |
1 |
| Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences | 172 |
1 |
| Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences | 162 |
1 |
| Tianjin University | 802 |
1 |
| Universidade Estadual de Campinas - Unicamp | 274 |
1 |
| The University of Adelaide | 155 |
1 |
| Instituto Butantan | 33 |
1 |
| Boehringer Ingelheim Animal Health USA Inc. | 418 |
1 |
| Biocentury Transgene (China) Co., Ltd | 85 |
1 |
| Bontac Invitrolife Bio-technology (Shenzhen) Co., Ltd | 16 |
1 |
| Autres propriétaires | 2 |